Log In
Print
BCIQ
Print
Print this Print this
 

AMG 337

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionSmall molecule inhibitor of c-Met receptor tyrosine kinase
Molecular Target c-Met receptor tyrosine kinase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today